O'Brien CP - Search Results

1

Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.

Pettinati HM, Kampman KM, Lynch KG, Suh JJ, Dackis CA, Oslin DW, O'Brien CP. Pettinati HM, et al. J Subst Abuse Treat. 2008 Jun;34(4):378-90. doi: 10.1016/j.jsat.2007.05.011. Epub 2007 Jul 30. J Subst Abuse Treat. 2008. PMID: 17664051 Free PMC article. Clinical Trial.

2

A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence.

Kampman K, Majewska MD, Tourian K, Dackis C, Cornish J, Poole S, O'Brien C. Kampman K, et al. Addict Behav. 2003 Apr;28(3):437-48. doi: 10.1016/s0306-4603(02)00226-5. Addict Behav. 2003. PMID: 12628617 Clinical Trial.

3

Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence.

Kampman KM, Volpicelli JR, Mulvaney F, Rukstalis M, Alterman AI, Pettinati H, Weinrieb RM, O'Brien CP. Kampman KM, et al. Addict Behav. 2002 Mar-Apr;27(2):251-60. doi: 10.1016/s0306-4603(01)00171-x. Addict Behav. 2002. PMID: 11817766

4

Concurrent cocaine withdrawal alters alcohol withdrawal symptoms.

Kampman KM, Pettinati H, Volpicelli J, Kaempf G, Turk E, Insua A, Lipkin C, Sparkman T, O'Brien CP. Kampman KM, et al. J Addict Dis. 2002;21(4):13-26. doi: 10.1300/J069v21n04_02. J Addict Dis. 2002. PMID: 12296498

5

Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study.

Dackis CA, Lynch KG, Yu E, Samaha FF, Kampman KM, Cornish JW, Rowan A, Poole S, White L, O'Brien CP. Dackis CA, et al. Drug Alcohol Depend. 2003 May 1;70(1):29-37. doi: 10.1016/s0376-8716(02)00335-6. Drug Alcohol Depend. 2003. PMID: 12681523 Clinical Trial.

6

A pilot trial of olanzapine for the treatment of cocaine dependence.

Kampman KM, Pettinati H, Lynch KG, Sparkman T, O'Brien CP. Kampman KM, et al. Drug Alcohol Depend. 2003 Jun 5;70(3):265-73. doi: 10.1016/s0376-8716(03)00009-7. Drug Alcohol Depend. 2003. PMID: 12757964 Clinical Trial.

7

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.

Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP. Oslin DW, et al. Neuropsychopharmacology. 2003 Aug;28(8):1546-52. doi: 10.1038/sj.npp.1300219. Epub 2003 Jun 18. Neuropsychopharmacology. 2003. PMID: 12813472 Clinical Trial.

8

Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcohol.

Kampman KM, Pettinati HM, Volpicelli JR, Oslin DM, Lipkin C, Sparkman T, O'Brien CP. Kampman KM, et al. Am J Addict. 2004 Jan-Feb;13(1):74-82. doi: 10.1080/10550490490265389. Am J Addict. 2004. PMID: 14766440 Clinical Trial.

9

A pilot trial of topiramate for the treatment of cocaine dependence.

Kampman KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, O'Brien CP. Kampman KM, et al. Drug Alcohol Depend. 2004 Sep 6;75(3):233-40. doi: 10.1016/j.drugalcdep.2004.03.008. Drug Alcohol Depend. 2004. PMID: 15283944

10

A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP. Dackis CA, et al. Neuropsychopharmacology. 2005 Jan;30(1):205-11. doi: 10.1038/sj.npp.1300600. Neuropsychopharmacology. 2005. PMID: 15525998 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters